ARCHIVES

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

First NCAB “Road” Hearing In L.A.

September 18, 1987

In Brief: John Mendelson To Succeed LaMaistre As President, M.D Anderson Cancer Center

May 17, 1996

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996